Kantarcıoğlu, BülentKaygusuz Atagündüz, IşıkUzay, AntToptaş, TayfurFıratlı Tuğlular, TulinBayık, Mahmut10.07.20192019-07-1010.07.20192019-07-102015Kantarcıoğlu, B., Kaygusuz Atagündüz, I., Uzay, A., Toptaş, T., Fıratlı Tuğlular, T. ve Bayık, M. (2015). Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature. International Journal of Hematology, 102(3), 383-387. https://dx.doi.org/10.1007/s12185-015-1792-20925-57101865-3774https://dx.doi.org/10.1007/s12185-015-1792-2https://hdl.handle.net/20.500.12511/2787WOS: 000360939400019PubMed ID: 25833723The human JAK2 gene is mainly targeted by two types of genetic lesions that play roles in the pathogenesis of hematologic malignancies: intragenic mutations and chromosomal translocations. Chromosomal translocations of JAK2 are typically associated with myeloid or lymphoid malignancies with an aggressive course and poor outcome. Here we report a t(9;22)(p24;q11.2) translocation, in a MDS patient and review results associated with BCR-JAK2 fusion reported in the literature.eninfo:eu-repo/semantics/openAccesst(9;22)Myelodysplastic SyndromeBCR-JAK2Fusion GeneJAK2 RearrangementReview Article102338338710.1007/s12185-015-1792-2Q3Q2